| Entry date | September 24, 2002 12:00 +1GMT
| | Last update | September 3, 2010 21:00 +1GMT
|
| Allergome Code | 51
|
| Name | Ara h 2 
|
| Previous Names | Ara h II
|
| Common Names | Conglutin, f423
|
| Biological Function | Trypsin Inhibitors
|
Isoforms, Variants, Epitopes | Ara h 2.0101, Ara h 2.0102, Ara h 2.0201, Ara h 2.0202
|
Links to Molecule Sequences | Ara h 2 - AX148738 - NCBI, Ara h 2 - AY581854 - NCBI, Ara h 2 - C0LJJ1 - UNIPROT, Ara h 2 - EF080817 - NCBI, Ara h 2 - Q6PSU2 - UNIPROT, Ara h 2.0101 - Q6PSU2 - UNIPROT, Ara h 2.0201 - Q6PSU2 - UNIPROT
|
| Links to AllFam | Prolamin superfamily
|
| Sources | |
Links to Source Taxonomy | Ara h - 26463 - ITIS, Ara h - 3818 - NCBI, Ara h - 3818 - UniProt-Taxonomy, Ara h - Wikipedia
|
| Links to Source Images | Ara h - bogaruhr04, Ara h - cornell23, Ara h - plantatlas07, Ara h - tipogov56, Ara h - viridis18
|
| Tissues | Seed
|
| Routes of Exposure | Ingestion
|
Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 3.2.1 - Source Sensitized (IgE) | 2010 | Sweden | IgE | 100 | 53.000 | 20100212, Asarnoj A
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2010 | Sweden | IgE | 50 | 0.000 | 20100212, Asarnoj A
| | 4.1.6 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 2.702 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.6 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 5.000 | 20091005, Ott H
| | 5.1.1 - Source Exposed (Symptoms) | 2007 | France | IgE | 47 | 93.600 | 20071022, Bernard H
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2007 | Netherlands | IgE | 20 | 100.000 | 20070615, Flinterman AE
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2007 | Netherlands | SPT | 9 | 100.000 | 20070615, Flinterman AE
| | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 2006 | France | IgE | 30 | 100.000 | 20060630, Astier C
| | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 2006 | France | SPT | 30 | 100.000 | 20060630, Astier C
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2006 | Germany | IgE | 16 | 62.500 | 20060711, Lin J
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2004 | Australia | IgE | 70 | 81.400 | 20040904, Hales BJ
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2004 | Netherlands | IgE (IB) | 32 | 81.200 | 20040416, Koppelman SJ
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2004 | Netherlands / Switzerland | IgE | 17 | 41.200 | 20041204, Mittag D
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2003 | France | IgE | 58 | 88.000 | 20031107, Bernard H
| | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 1999 | Not Defined | IgE (IB) | 40 | 85.000 | 1999, Kleber-Janke T
|
| | Reagents | 1) Molecule - Indoor Biotechnologies 4) Diagnostic (in vitro) - Phadia - VBC-Genomics |
| References | Biochemistry / Structure / Function 2010: 20100706, Koppelman SJ
- 20100622, Johnson PE
- 20100621, Radosavljevic J
- 20100614, Liu H
- 20100506, Schmidt H
- 20100311, Faeste CK
2009: 20091125, Li J
- 20090808, Dooper MM
- 20090717, Schmidt H
- 20090712, Albrecht M
- 20090522, Bernard H
- 20090511, Porterfield HS
- 20090218, Chassaigne H
2008: 20081203, Stevenson SE
- 20081114, Ramos ML
- 20081114, Chu Y
- 20081105, Kopper RA
- 20081103, Clare DA
- 20081028, Ivanciuc O
- 20081027, Ivanciuc O
... complete Reference listing ->
Molecular Biology 2010: 20100621, Radosavljevic J
2009: 20090811, Roesler E
2008: 20081203, Stevenson SE
- 20081114, Chu Y
2007: 20070905, Dodo HW
- 20070822, Glenting J
- 20070430, Kang IH
2006: 20060630, Astier C
2005: 20050929, King N
- 20050923, Sforza S
- 20050810, Yan YS
- 20050125, Dodo H
2004: 20040904, Hales BJ
- 20040611, Stephan O
2003: 20031017, Lehmann K
2001: 2001, Viquez OM
2000: 2000, Kleber-Janke T
1999: 1999, Kleber-Janke T
1997: 1997, Stanley JS
Immunochemistry / Allergenicity 2010: 20100621, Radosavljevic J
- 20100614, Liu H
2009: 20090808, Dooper MM
- 20090717, Schmidt H
- 20090712, Albrecht M
- 20090622, Ocmant A
- 20090615, Blanc F
- 20090522, Bernard H
- 20090218, Chassaigne H
2008: 20081114, Chu Y
- 20081103, Clare DA
- 20081028, Ivanciuc O
- 20080826, Marsh J
- 20080805, Guo B
- 20080122, Riecken S
2007: 20071112, El-Khouly F
- 20071022, Bernard H
- 20071004, Gubesch M
- 20070907, Lin J
- 20070905, Dodo HW
... complete Reference listing ->
Immune-mechanisms / Genetics 2010: 20100113, Flinterman AE
2009: 20090703, Jones SM
2005: 20050929, King N
2004: 20041207, Glaspole IN
2003: 2003, Turcanu V
1998: 1998, van Reijsen FC
1994: 1994, Dorion BJ
Detection - Source Extracts, Food Products, Drug Preparations 2009: 20091223, Schmitt DA
- 20091029, Krause S
- 20090717, Schmidt H
- 20090528, Scaravelli E
2008: 20081203, Stevenson SE
- 20081114, Chu Y
- 20080805, Guo B
- 20080218, Careri M
2007: 20071004, Gubesch M
- 20070927, Careri M
- 20070531, Kang IO
- 20070518, Chassaigne H
- 20070503, Chassaigne H
- 20070430, Kang IH
- 20070420, McDermott RA
2006: 20061128, Kaul S
- 20060824, Thottingal TB
2005: 20050923, Sforza S
- 20050410, Poms RE
- 20050201, Schmitt DA
... complete Reference listing ->
Detection - Allergy Diagnostic and Immunotherapeutic Products 1995: 1995, Hefle SL
Detection - Source Tissues 2007: 20070905, Dodo HW
- 20070430, Kang IH
Detection - Body Biodistribution 2001: 2001, Vadas P
Epidemiology 2009: 20090826, Ebo DG
1999: 1999, Kleber-Janke T
Diagnosis 2010: 20100531, Thompson JC
- 20100316, Cabanos C
- 20100212, Asarnoj A
- 20100101, Nicolau N
2009: 20091121, Ebo DG
- 20091005, Ott H
- 20090826, Ebo DG
- 20090808, Krause S
- 20090622, Ocmant A
- 20090615, Blanc F
- 20090505, Vidal C
- 20090210, Yagami A
2008: 20081230, Adachi A
2007: 20070615, Flinterman AE
- 20070420, McDermott RA
2006: 20061223, Peters KA
- 20060711, Lin J
- 20060630, Astier C
2005: 20051008, Shreffler WG
- 20050517, Palmer GW
... complete Reference listing ->
Experimental Model - Allergic Immune Response 2009: 20090811, Roesler E
2008: 20080211, Proust B
2006: 20061223, Adel-Patient K
- 20061212, de Jonge JD
Experimental Model - Ingestion-induced Diseases 2005: 20050501, van Wijk F
- 20050410, Adel-Patient K
2004: 20041224, van Wijk F
- 20040907, Van Wijk F
2003: 20030713, Li XM
- 2003, Li XM
2000: 2000, Li XM
1999: 1999, Roy K
- 1999, Li X
Experimental Model - Skin-induced Diseases 2006: 20061223, Adel-Patient K
Review, Editorial, Report Citations, Other Resources 2010: 20100721, Stevenson SE
- 20100611, Lucas JM
- 20100610, Kemp A
- 20100527, Scurlock AM
- 20100430, Wang J
- 20100412, Karp CL
- 20100312, Wang J
- 20100226, Turcanu V
- 20100216, Rance F
- 20100101, Sicherer SH
2009: 20091231, Sicherer SH
- 20091210, Thyagarajan A
- 20091210, Jappe U
- 20091204, Harrer A
- 20091121, Knol EF
- 20091119, Riascos JJ
- 20091008, Yano H
- 20091006, Alessandri C
- 20091005, Ladics GS
- 20090809, Jacquenet S
... complete Reference listing -> |
|